Digital health - May 27, 2026
Skape Bio launches platform for AI-designed GPCR biotherapeutics
Skape Bio and researchers at the University of Washington’s Institute for Protein Design (IPD) have announced a peer-reviewed study published in Nature demonstrating a new way to design protein-based medicines for G protein-coupled receptors, or GPCRs.
Collaboration - May 11, 2026
Bactiguard and BD strengthen global partnership
Bactiguard Holding has announced an update to its long standing collaboration with license partner BD (Becton, Dickinson & Company) through the signing of a restated long-term agreement.
Intellectual Property - May 4, 2026
Gradientech receives US patent allowance
Gradientech has received a Notice of Allowance in the United States for its single-use microfluidic test, a key component of the CE marked QuickMIC system.
Digital health - April 23, 2026
Karolinska Institutet opens new AI center
The purpose of the Karolinska Institutet Centre for AI Innovation is to serve as a support centre and skills hub.
Digital health - April 16, 2026
New study: AI identifies early risk patterns for skin cancer
Healthcare registry data can show early risk patterns for melanoma skin cancer, according to a study from the University of Gothenburg.
Agreement - April 15, 2026
Novo Nordisk partners with OpenAI
The partnership will apply advanced AI capabilities to analyse complex datasets, identify promising drug candidates, and reduce the time required to move from research to patient, the company states.
